National Cancer Center East

Kashiwa-Shi, Chiba 277-8577

0 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic Solid Tumors, Solid Tumors

Studies at this site

• Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors — Running, not enrolling
• A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors — Completed